Molecular and physical characterization of Burkholderia mallei O antigens - PubMed (original) (raw)
Molecular and physical characterization of Burkholderia mallei O antigens
Mary N Burtnick et al. J Bacteriol. 2002 Feb.
Abstract
Burkholderia mallei lipopolysaccharide (LPS) has been previously shown to cross-react with polyclonal antibodies raised against B. pseudomallei LPS; however, we observed that B. mallei LPS does not react with a monoclonal antibody (Pp-PS-W) specific for B. pseudomallei O polysaccharide (O-PS). In this study, we identified the O-PS biosynthetic gene cluster from B. mallei ATCC 23344 and subsequently characterized the molecular structure of the O-PS produced by this organism.
Figures
FIG. 1.
(A) Western blot analysis of B. mallei ATCC 23344. Proteinase K-treated whole-cell lysates were used. In lane 1, the primary antibody used was a 1/2,000 dilution of polyclonal antisera raised against a B. pseudomallei BSA-O-PS conjugate, and in lane 2, the primary antibody used was a 1/2,000 dilution of the B. pseudomallei O-PS-specific MAb (Pp-PS-W). (B) Western blot profiles of proteinase K-treated whole-cell lysates of B. mallei strains. The primary antibody used was polyclonal sera raised against a B. pseudomallei BSA-O-PS conjugate. Lanes: 1, NCTC 120; 2, NCTC 10248; 3, NCTC 10229; 4, NCTC 10260; 5, NCTC 10247; 6, ATCC 23344; 7, NCTC 3708; 8, NCTC 3709; 9, ATCC 10399; and 10, ATCC 15310. (C) Silver stain analysis of proteinase K-treated whole-cell lysates of B. mallei strains. Lanes: 1, NCTC 120; 2, NCTC 10248; 3, NCTC 10229; 4, NCTC 10260; 5, NCTC 10247; 6, ATCC 23344; 7, NCTC 3708; 8, NCTC 3709; 9, ATCC 10399; and 10, ATCC 15310.
FIG. 2.
Restriction and genetic maps of the B. mallei O-PS biosynthetic gene cluster. (A) Restriction map. The horizontal line represents the B. mallei DNA insert of cosmid 2B5. The locations of _Bam_HI and _Kpn_I cleavage sites used for subcloning are shown. Two additional _Bam_HI sites at the 5′ and 3′ ends of 2B5, which were part of the pScosBC1 vector, are not shown. (B) Genetic map. The location and direction of transcription of the genes are represented by arrows, and the gene names are shown below. The gray arrows indicate the genes involved in O-PS biosynthesis based on homology to the B. pseudomallei O-PS biosynthetic operon.
FIG. 3.
13C-NMR analysis of B. mallei PB100 O-PS. (A) _O_-Acetyl peaks are indicated by stars. (B) Expanded view of the region running from 100 to 60 ppm. (C) Structure of B. pseudomallei and B. mallei O-PS. In B. pseudomallei, in 33% of the talose residues, R′ = _O_-methyl and R" = _O_-acetyl, and in 66% of the talose residues, R′ = _O_-acetyl and R" = OH. In B. mallei, R′ = _O_-acetyl or _O_-methyl and R" = OH.
FIG. 4.
Serum bactericidal assays with B. mallei strains. (A) Thirty percent NHS killing assay in which viable counts were determined at the 2-, 4-, 8-, and 18-h time points. B. pseudomallei 1026b (▴), B. mallei ATCC 23344 (⧫), and E. coli HB101 (•). (B) Thirty percent NHS killing assay in which viable counts were determined following a 2-h incubation at 37°C. Control tubes containing phosphate-buffered saline (PBS) are shown as white bars, and experimental tubes containing 30% NHS are shown as gray bars. Error bars indicate standard deviations.
Similar articles
- Antigenic relatedness between Burkholderia pseudomallei and Burkholderia mallei.
Anuntagool N, Sirisinha S. Anuntagool N, et al. Microbiol Immunol. 2002;46(3):143-50. doi: 10.1111/j.1348-0421.2002.tb02679.x. Microbiol Immunol. 2002. PMID: 12008922 - Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.
Moustafa DA, Scarff JM, Garcia PP, Cassidy SK, DiGiandomenico A, Waag DM, Inzana TJ, Goldberg JB. Moustafa DA, et al. PLoS One. 2015 Jul 6;10(7):e0132032. doi: 10.1371/journal.pone.0132032. eCollection 2015. PLoS One. 2015. PMID: 26148026 Free PMC article. - The wbiA locus is required for the 2-O-acetylation of lipopolysaccharides expressed by Burkholderia pseudomallei and Burkholderia thailandensis.
Brett PJ, Burtnick MN, Woods DE. Brett PJ, et al. FEMS Microbiol Lett. 2003 Jan 28;218(2):323-8. doi: 10.1111/j.1574-6968.2003.tb11536.x. FEMS Microbiol Lett. 2003. PMID: 12586411 - Development of mouse hybridomas for production of monoclonal antibodies specific to Burkholderia mallei and Burkholderia pseudomallei.
Feng SH, Tsai S, Rodriguez J, Newsome T, Emanuel P, Lo SC. Feng SH, et al. Hybridoma (Larchmt). 2006 Aug;25(4):193-201. doi: 10.1089/hyb.2006.25.193. Hybridoma (Larchmt). 2006. PMID: 16934015 - Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?
Titball RW, Burtnick MN, Bancroft GJ, Brett P. Titball RW, et al. Vaccine. 2017 Oct 20;35(44):5981-5989. doi: 10.1016/j.vaccine.2017.03.022. Epub 2017 Mar 21. Vaccine. 2017. PMID: 28336210 Review.
Cited by
- Development of novel O-polysaccharide based glycoconjugates for immunization against glanders.
Burtnick MN, Heiss C, Schuler AM, Azadi P, Brett PJ. Burtnick MN, et al. Front Cell Infect Microbiol. 2012 Nov 27;2:148. doi: 10.3389/fcimb.2012.00148. eCollection 2012. Front Cell Infect Microbiol. 2012. PMID: 23205347 Free PMC article. - Detection of Burkholderia pseudomallei O-antigen serotypes in near-neighbor species.
Stone JK, Mayo M, Grasso SA, Ginther JL, Warrington SD, Allender CJ, Doyle A, Georgia S, Kaestli M, Broomall SM, Karavis MA, Insalaco JM, Hubbard KS, McNew LA, Gibbons HS, Currie BJ, Keim P, Tuanyok A. Stone JK, et al. BMC Microbiol. 2012 Nov 5;12:250. doi: 10.1186/1471-2180-12-250. BMC Microbiol. 2012. PMID: 23126230 Free PMC article. - Burkholderia pseudomallei type III secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages.
Burtnick MN, Brett PJ, Nair V, Warawa JM, Woods DE, Gherardini FC. Burtnick MN, et al. Infect Immun. 2008 Jul;76(7):2991-3000. doi: 10.1128/IAI.00263-08. Epub 2008 Apr 28. Infect Immun. 2008. PMID: 18443088 Free PMC article. - Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies.
Parthasarathy N, DeShazer D, England M, Waag DM. Parthasarathy N, et al. Diagn Microbiol Infect Dis. 2006 Nov;56(3):329-32. doi: 10.1016/j.diagmicrobio.2006.04.018. Epub 2006 Jun 12. Diagn Microbiol Infect Dis. 2006. PMID: 16765554 Free PMC article. - Burkholderia mallei cellular interactions in a respiratory cell model.
Whitlock GC, Valbuena GA, Popov VL, Judy BM, Estes DM, Torres AG. Whitlock GC, et al. J Med Microbiol. 2009 May;58(Pt 5):554-562. doi: 10.1099/jmm.0.007724-0. J Med Microbiol. 2009. PMID: 19369515 Free PMC article.
References
- Centers for Disease Control and Prevention. 2000. Laboratory acquired human glanders—Maryland May 2000. Morb. Mortal. Wkly. Rep. 49:532–533. - PubMed
- DeShazer, D., P. J. Brett, and D. E. Woods. 1998. The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence. Mol. Microbiol. 30:1081–1100. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous